Capsugel
Lonza to work with Rockwell Automation on digital transformation project
Biotech company Lonza has announced it will work with Rockwell Automation to help digitally transform nine of its former Capsugel facilities. Read more
Capsugel expands capabilities at Edinburgh facility
Capsugel, now a Lonza company, has expanded the clinical trial capabilities, as well as increased development and manufacturing capabilities for specialised drug products using liquid-filled hard capsule (LFHC) technology, at its Edinburgh facility. Read more
Win-win-win! CPhI Pharma Awards winners revealed
The organisers of CPhI Worldwide have revealed the winners of the 14th Pharma Awards. Read more
Lonza completes acquisition of Capsugel
Lonza has announced that, following receipt of all required regulatory approvals, it has completed its acquisition of Capsugel for $5.5 billion in cash, including refinancing of existing Capsugel debt of $2 billion. Read more
Lonza has received regulatory approval for Capsugel acquisition
Lonza has revealed it has gained all regulatory approvals for its proposed acquisition of Capsugel, which the company anticipates will close over the next few days subject to the satisfaction of customary closing conditions. Read more
A dose of news — a round-up of the latest in drug delivery
In this brief news round-up, we discuss recent news, breakthroughs and updates in the drug delivery sector, including vaping medicinal cannabis and a molecular slingshot. Read more
Lonza acquires Capsugel for $5.5 billion
Capsule specialist Capsugel is acquired by major pharma player Lonza, and investment firm KKR. Read more
Capsugel launches new capsule for enteric protection
Leader in dosage forms and solutions Capsugel, has announced the launch of its Vcaps Enteric capsules. Read more
Capsugel investing in enhanced micronisation capacity and capabilities
Global manufacturer in dosage forms and solutions Capsugel are expanding their Quakertown facility to meet customer demands for their micronisation services. Read more
One step up: achieving compliance for excipient GMPs
Kaat Bracquiné, quality and regulatory affairs, Capsugel explains how to achieve compliance with the new EU guidelines for excipient GMPs Read more
Capsugel offers micro-dosing in Europe and US
Capsugel is expanding its micro-dosing services offering for early-phase feasibility work Read more
Pharmaceutical breakthroughs of 2015: Editor's Picks
As always innovation has been a key element in this year’s pharmaceutical sector. Lu Rahman handpicks her favourite stories showing the breakthroughs that have taken place over the last 12 months Read more
Why high potency drugs require a specialised approach
Stephen Brown, Encap Drug Delivery, a division of Capsugel Dosage Form Solutions describes why the safe manufacturing of high potency drugs requires a specialised approach Read more
Putting quality first in development and manufacturing
Capsugel’s Steven Facer says prioritisation of quality and regulatory compliance from the start is key to achieving long-term gains for emerging markets Read more
Capsugel doubles capacity at Edinburgh facility
Capsugel is set to more than double the size of its facility in Edinburgh, Scotland, enabling the company to meet rising customer demand for its liquid- and semi-solid-fill hard capsule development and manufacturing services. Read more
New commercial spray-dried dispersion facility does Capsugel proud
A new pharmaceutical spray-dried dispersion commercial manufacturing facility at Capsugel's site in Bend, Ore, US, is ready for business. Read more
Inhalation technologies to treat wider range of diseases
Capsugel has manufactured Phase 2 clinical trial supplies for a dry powder inhalation formulation that efficiently delivers biotherapeutics to the lung. Read more
Vegetarian capsules chosen by Quest for probiotic line
UK-based Quest Vitamins Ltd has selected Capsugel’s vegetarian DRcaps capsules to encapsulate its popular Biotix probiotics product line. DRcaps capsules, made with a hypromellose (HPMC) formulation, offer a versatile... Read more
Capsugel enters agreement with Chiasma for scale-up manufacture of oral ocreotide acetate
Capsugel has announced an agreement with Chiasma, Inc., wherein Capsugel’s dosage form solutions (DFS) business unit is scaling up manufacturing for what is claimed to be the only investigational oral form of octreotide in clinical development. Read more
